Nov 13 |
CARGO Therapeutics GAAP EPS of -$0.88
|
Nov 12 |
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
|
Oct 18 |
Here's Why We're Not Too Worried About CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Situation
|
Aug 16 |
Why Cargo Therapeutics Stock Rocketed Nearly 20% Higher This Week
|
Jul 29 |
With 54% ownership of the shares, CARGO Therapeutics, Inc. (NASDAQ:CRGX) is heavily dominated by institutional owners
|
Jul 10 |
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
|
Jun 4 |
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
|
Jun 4 |
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
|
May 28 |
CARGO Therapeutics looks to raise $110M through equity financing
|
May 28 |
CARGO Therapeutics to Participate in Upcoming Investor Conferences
|